About the

Conference Chair

In 2003, Dr. Tomader started her journey in the field of diabetes investigating effects on nitrates on angina in diabetes models. She then transitioned to industry in 2004, working in Genetic Rare Diseases managing UK patients with Gaucher's and Fabry's disease at Genzyme Therapeutics (Sanofi) in her hometown of Oxford.

Tomader completed her specialized Master of Research (MRes) program in 2006 focusing on the differential detrimental effects of saturated and unsaturated fatty acids in Type 2 Diabetes, while also being a recipient of the EU Exchange Program in Sweden working on the molecular genetics of Acute Myeloid Leukaemia (AML).

In 2007, Tomader was awarded a Diabetes UK PhD Scholarship delineating cellular and drug responses pathway in diabetes drugs (metformin, rosiglitazone and pioglitazone) via cell culture, gene expression and functional work, vector virus design and imaging, later expanding into primary cell line, stem cell differentiation, and pancreatic cancer models.

Receiving an NIH Fellowship in the United States in 2011 at the Comprehensive Diabetes Centre at UAB, Dr Tomader worked and published on lipids and pancreatic beta-cell apoptosis mechanisms in T1DM (cell, animal and human islets) and R&D/new drug pharmacological characterization while managing projects, grants, teaching, mentoring and running specialized facilities such as animal surgery and radioactivity laboratories.

Following being an Executive Member of various educational activities (under- and postgraduate), and public health outreach programs, Dr. Tomader became Head of The Office of Undergraduate Research. Her NSF training at the Center for the Integration of Research, Teaching, and Learning (CIRTL) enabled the creation of multiple education and training programs, and initiatives such as the first chapter of the American Physiological Society (APS) in the state of Alabama.

Leaving the USA, in 2015 Dr Tomader was invited to join the educational reform movement in the UAE as Assistant Professor at Sheikha Fatima College of Health Sciences; AD, AA and Adjunct Faculty at Monash University. She taught the Australian Integrated Clinical Therapeutics curriculum at the Dept. of Pharmacy in Cardiology, Oncology and Immunology as well as Public Health and Communication in Health Care.

Upon joining the Research Institute at ICLDC, as a Fellow and Project Lead in the Clinical Research Team, and as Organizer and Core Faculty of IDET, Dr Tomader worked with multiple departments integrating research, education and strategic planning. She is currently an accredited Certified Professional by the Association of Clinical Research Professionals. Over the years Dr. Tomader served on various internal and external boards and committees, forging strong relationships with governing, accreditation and stakeholder bodies.